Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J During

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Lancet (London, England)|August 31, 1996
Gene trial in New ZealandM J During
Clinical Neuroscience (New York, N.Y.)|January 1, 1995
Adeno-associated virus vectors for gene therapy of neurodegenerative disordersM J During, P Leone
Experimental Neurology|March 1, 1997
Targets for gene therapy of Parkinson's disease: growth factors, signal transduction, and promotersM J During, P Leone
The Australian and New Zealand Journal of Psychiatry|December 1, 1988
Is L-tryptophan safe?M J During, A Freese
Journal of Neuroscience Methods|August 1, 1995
Combining laser Doppler flowmetry with microdialysis: a novel approach to investigate the coupling of regional cerebral blood flow to neuronal activityM G Kaiser, M J During
Annals of Neurology|July 1, 1990
A cautionary note on the potential benefits of striatal dopamine implantsA Y Deutch, M J During
Annals of Neurology|November 1, 1992
Adenosine: a potential mediator of seizure arrest and postictal refractorinessM J During, D D Spencer
Nature Biotechnology|August 3, 1999
PNAs breach the blood-brain barrier?M J During, C G Janson
Genomics|November 15, 2001
Viral vectors as part of an integrated functional genomics programC G Janson, M J During
Molecular Medicine Today|December 19, 1998
Towards gene therapy for the central nervous systemM J During, L M Ashenden
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Lancet (London, England)|August 31, 1996
Gene trial in New ZealandM J During
Clinical Neuroscience (New York, N.Y.)|January 1, 1995
Adeno-associated virus vectors for gene therapy of neurodegenerative disordersM J During, P Leone
Experimental Neurology|March 1, 1997
Targets for gene therapy of Parkinson's disease: growth factors, signal transduction, and promotersM J During, P Leone
The Australian and New Zealand Journal of Psychiatry|December 1, 1988
Is L-tryptophan safe?M J During, A Freese
Journal of Neuroscience Methods|August 1, 1995
Combining laser Doppler flowmetry with microdialysis: a novel approach to investigate the coupling of regional cerebral blood flow to neuronal activityM G Kaiser, M J During
Annals of Neurology|July 1, 1990
A cautionary note on the potential benefits of striatal dopamine implantsA Y Deutch, M J During
Annals of Neurology|November 1, 1992
Adenosine: a potential mediator of seizure arrest and postictal refractorinessM J During, D D Spencer
Nature Biotechnology|August 3, 1999
PNAs breach the blood-brain barrier?M J During, C G Janson
Genomics|November 15, 2001
Viral vectors as part of an integrated functional genomics programC G Janson, M J During
Molecular Medicine Today|December 19, 1998
Towards gene therapy for the central nervous systemM J During, L M Ashenden
Pageof 9